Search

A study conducted by researchers at Sichuan University in Chengdu, China, explores the potential of messenger RNA (mRNA) as a therapeutic agent for preventing and treating diseases, particularly in the field of cancer immunotherapy. The study highlights the challenges of mRNA instability and inefficient in vivo delivery, but also discusses recent technological advancements that address these challenges. The researchers provide an overview of non-viral vectors used for mRNA vaccine delivery and discuss preclinical and clinical studies in cancer immunotherapy. They emphasize the importance of ongoing research in mRNA-based therapeutics and highlight future possibilities and remaining challenges in mRNA delivery technology. [Extracted from the article]

We designed the nanocomposite DMPM to deliver pIL-12 for cancer treatment and explored its therapeutic efficacy and the underlying anti-tumor mechanism." Keywords: Chengdu; People's Republic of China; Asia; Bioengineering; Biotechnology; Cancer; Cancer Gene Therapy; Cancer Therapy; Drugs and Therapies; Emerging Technologies; Gene Therapy; Health and Medicine; Nanotechnology; Nanovectors; Oncology; Pharmaceuticals EN Chengdu People's Republic of China Asia Bioengineering Biotechnology Cancer Cancer Gene Therapy Cancer Therapy Drugs and Therapies Emerging Technologies Gene Therapy Health and Medicine Nanotechnology Nanovectors Oncology Pharmaceuticals 20 20 1 11/06/23 20231106 NES 231106 2023 NOV 6 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Fresh data on Biotechnology - Cancer Gene Therapy are presented in a new report. [Extracted from the article]